Figure 3

![Figure 3: Resveratrol's effects on hepatic lipid accumulation in preclinical MASLD models are summarized, including reductions in triglyceride content and steatosis scores.]()

> Source: Kamila Kasprzak-Drozd et al. "Does Resveratrol Improve Metabolic Dysfunction-Associated Steatotic Liver Diseas." *International journal of molecular sciences*, 2024. PMID: [38612556](https://pubmed.ncbi.nlm.nih.gov/38612556/)

<figure>
  <img src="" alt="Resveratrol's effects on hepatic lipid accumulation in preclinical MASLD models are summarized, including reductions in triglyceride content and steatosis scores." />
  <figcaption>Figure 3. Resveratrol's effects on hepatic lipid accumulation in preclinical MASLD models are summarized, including reductions in triglyceride content and steatosis scores.<br>  Source: Kamila Kasprzak-Drozd et al. "Does Resveratrol Improve Metabolic Dysfunction-Associated Steatotic Liver Diseas." <em>International journal of molecular sciences</em>, 2024. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/38612556/">38612556</a></figcaption>
</figure>